Business Description
Aspira Pathlab & Diagnostics Ltd
ISIN : INE500C01017
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.5 | |||||
Equity-to-Asset | 0.69 | |||||
Debt-to-Equity | 0.27 | |||||
Debt-to-EBITDA | -81.11 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 5.23 | |||||
Beneish M-Score | -3.6 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -7 | |||||
3-Year FCF Growth Rate | -48.6 | |||||
3-Year Book Growth Rate | 44.2 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 54.46 | |||||
9-Day RSI | 54.88 | |||||
14-Day RSI | 54.42 | |||||
6-1 Month Momentum % | -5.28 | |||||
12-1 Month Momentum % | -8.79 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.1 | |||||
Quick Ratio | 1.89 | |||||
Cash Ratio | 0.67 | |||||
Days Inventory | 40.92 | |||||
Days Sales Outstanding | 52.3 | |||||
Days Payable | 51.91 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | 0.16 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 74.61 | |||||
Operating Margin % | -13.35 | |||||
Net Margin % | -12.53 | |||||
FCF Margin % | 5.18 | |||||
ROE % | -16.74 | |||||
ROA % | -11.91 | |||||
ROIC % | -15.23 | |||||
3-Year ROIIC % | -155.75 | |||||
ROC (Joel Greenblatt) % | -22.07 | |||||
ROCE % | -11 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Price-to-Owner-Earnings | 60.06 | |||||
PS Ratio | 2.17 | |||||
PB Ratio | 3.35 | |||||
Price-to-Tangible-Book | 4.48 | |||||
Price-to-Free-Cash-Flow | 42.97 | |||||
Price-to-Operating-Cash-Flow | 32.19 | |||||
EV-to-EBIT | -22.4 | |||||
EV-to-EBITDA | -1017.27 | |||||
EV-to-Revenue | 2.29 | |||||
EV-to-FCF | 43.79 | |||||
Price-to-Projected-FCF | 22.14 | |||||
Earnings Yield (Greenblatt) % | -4.46 | |||||
FCF Yield % | 2.36 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Aspira Pathlab & Diagnostics Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 152.384 | ||
EPS (TTM) (₹) | -1.85 | ||
Beta | -0.23 | ||
Volatility % | 28.79 | ||
14-Day RSI | 54.42 | ||
14-Day ATR (₹) | 1.747067 | ||
20-Day SMA (₹) | 32.05 | ||
12-1 Month Momentum % | -8.79 | ||
52-Week Range (₹) | 25 - 43.95 | ||
Shares Outstanding (Mil) | 10.29 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Aspira Pathlab & Diagnostics Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Aspira Pathlab & Diagnostics Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Aspira Pathlab & Diagnostics Ltd Frequently Asked Questions
What is Aspira Pathlab & Diagnostics Ltd(BOM:540788)'s stock price today?
When is next earnings date of Aspira Pathlab & Diagnostics Ltd(BOM:540788)?
Does Aspira Pathlab & Diagnostics Ltd(BOM:540788) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |